SD BioScience Signs Business Agreement with Spirulina Farms for Health Food Ingredient Development

[Asia Economy Reporter Jang Hyowon] SD Bioengineering, a company specializing in the manufacturing and sales of cosmetics and health supplements (CEO Park Seol-woong), announced on the 13th that it has signed a business agreement with Spirulina Farms (CEO Han Myung-ho) for joint research and development and manufacturing of health supplement materials. At the signing ceremony, SD Bioengineering Chairman Park Seol-woong and Spirulina Farms CEO Han Myung-ho attended and exchanged opinions on the future roadmap.

Spirulina Farms, located in Naju, Jeollanam-do, possesses mass cultivation technology and patents for microalgae Spirulina production and supplies raw materials for health supplements and cosmetics.

Spirulina is widely known as a beauty and health supplement ingredient rich in dietary fiber and protein, but most of it is imported. This ingredient is a functional material certified by the Ministry of Food and Drug Safety and contains 49 types of nutrients and 12 types of vitamins. Its antioxidant effect from phycocyanin effectively acts as an anti-aging agent. Additionally, the main component chlorophyll has been confirmed through numerous studies to reduce pancreatic cancer tumor size and protect cells from carcinogens.

Through this agreement, the two companies will mutually cooperate on ▲ development of natural raw materials for health functional foods ▲ joint development of natural cosmetic materials, eco-friendly pet food and additives, and new pharmaceutical materials ▲ strengthening investment and cooperation foundations such as joint marketing and sales activities ▲ expanding product supply capabilities utilizing SD Bioengineering’s health supplement manufacturing technology.

A company official stated, “Our company has production lines and facility capabilities that can simultaneously handle various formulations such as soft capsules, hard capsules, tablets, powders, and liquids,” adding, “We will strive to achieve visible results based on stable technological capabilities.”

The company completed its second health supplement manufacturing plant in the Wonnam Industrial Complex, Eumseong, Chungbuk, in June and has begun full-scale operations. It is currently pursuing technical partnerships and business agreements related to health supplement manufacturing with various manufacturers and distributors.

This content was produced with the assistance of AI translation services.